z-logo
open-access-imgOpen Access
PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
Author(s) -
Abdelrahman Y. Sherif,
Gamaleldin I. Harisa,
Fars K. Alanazi,
Fahd A. Nasr,
Ali S. Alqahtani
Publication year - 2022
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s365974
Subject(s) - solid lipid nanoparticle , gefitinib , cytotoxicity , zeta potential , in vivo , pharmacology , ex vivo , medicine , chemistry , cancer , nanotechnology , in vitro , materials science , nanoparticle , biochemistry , biology , epidermal growth factor receptor , drug , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here